Health Sciences PhD Program, Universidad Católica de Murcia UCAM, Murcia, Spain.
Department of Occupational Therapy, Universidad Catolica de Murcia UCAM, Murcia, Spain.
Eur J Cancer Care (Engl). 2022 Sep;31(5):e13642. doi: 10.1111/ecc.13642. Epub 2022 Jul 12.
In palliative care, the prevention and relief of fatigue are regarded as crucial goals in patients with cancer.
A systematic review was carried out according to the COnsensus-based Standards for the selection of health status Measurement INstruments methodology. Searches were conducted in Medline (through PubMed), Web of Science, Open Gray, Scielo, Cochrane, CINAHL and EMBASE. All instruments found in each study were assessed using the COnsensus-based Standards for the selection of health status Measurement INstruments checklist and Grading of Recommendations, Assessment, Development and Evaluation approach.
A total of 5598 articles were identified in the different databases. In total, 57 studies describing 19 instruments were included in this study. The main properties evaluated were internal consistency, cross-cultural validity, hypotheses testing and responsiveness. All studies were evaluated with the Strobe scale with a score greater than 6 points.
According to the quality methodological results, Edmonton Symptom Assessment System, Problems and Needs in Palliative Care Questionnaire, European Organisation for Research and Treatment of Cancer Quality of Life 15-item Questionnaire for Palliative Care and Palliative Care Quality of Life Instrument are the recommended instruments used for assessing cancer-related fatigue in palliative care. PROPESRO registration number: CRD42020206783.
在姑息治疗中,预防和缓解疲劳被视为癌症患者的重要目标。
根据共识标准选择健康状况测量工具方法进行系统评价。在 Medline(通过 PubMed)、Web of Science、Open Gray、Scielo、Cochrane、CINAHL 和 EMBASE 中进行了搜索。在每项研究中找到的所有工具都使用共识标准选择健康状况测量工具清单和推荐评估、发展和评估方法进行评估。
在不同的数据库中总共确定了 5598 篇文章。共有 57 项研究描述了 19 种工具被纳入本研究。评估的主要特性包括内部一致性、跨文化有效性、假设检验和反应性。所有研究均用 Strobe 量表进行评估,得分均大于 6 分。
根据高质量的方法学结果,埃德蒙顿症状评估系统、姑息治疗中的问题和需求问卷、欧洲癌症研究与治疗组织生活质量 15 项问卷用于姑息治疗和姑息治疗生活质量工具是推荐用于评估癌症相关疲劳的工具。PROPESRO 注册号:CRD42020206783。